Financial Hardship Followed Cancer Treatment
Patients managing cancer often face long-term economic strain alongside complex medical recovery.
Updated on Oct. 12, 2026 in Cancer
Following her stage 4 Hodgkin lymphoma diagnosis in 2012, Erica Campbell completed 12 rounds of chemotherapy in 2013 while navigating significant income loss. This highlights the ongoing challenge of financial toxicity that can persist long after active treatment concludes.
Why it matters
Cancer treatment frequently triggers financial toxicity through a combination of high medical costs and reduced earnings during medical leave. This economic pressure complicates recovery and underscores the importance of support systems for patients managing long-term health effects.
National statistics indicate that 7 in 10 people survive cancer for more than five years after diagnosis. The long-term economic consequences, such as those faced by survivors requiring procedures like double hip replacements, are still being investigated by advocacy groups.
The players
Erica Campbell
A cancer survivor who documented the financial and physical challenges following her stage 4 Hodgkin lymphoma treatment.
Lymphoma Research Foundation
A national organization that provides research funding and support services for patients affected by lymphoma.
The details
Financial toxicity occurs when the combined weight of medical bills and lost wages overwhelms a patient's resources. Campbell, who required four power port surgeries and received only 60% of her salary during leave, highlights how treatment impacts can necessitate long-term care, including secondary orthopedic surgeries. Patients often manage these costs through health insurance and targeted grants from organizations like the Lymphoma Research Foundation.
Timeline
2012: Erica Campbell received a cancer diagnosis.
2013: Erica Campbell finished chemotherapy treatment.
2012-2022: Campbell attended monthly oncology appointments for 10 years.
2025-2026: Lymphoma Research Foundation saw an increase in grant applications.
Health Landscape
The trend of increasing grant applications reported by the Lymphoma Research Foundation suggests that financial toxicity remains a prevalent issue in oncology. This highlights a shift in care models that now increasingly include financial counseling alongside traditional medical treatment.
If you are managing a cancer diagnosis, discuss potential financial assistance programs with your oncology team early in the treatment process. It is also worth reviewing your insurance benefits to understand your coverage for both acute care and potential long-term rehabilitation.
The takeaway
Cancer survival is a multi-year process that often extends well beyond the final round of chemotherapy. Patients should proactively track all medical costs and consult their care team about available patient advocacy grants that can help mitigate long-term financial strain.
Further reading
Learn more about support resources in the Cancer section.
Source note: This article includes information reported by NBC4 Washington.
